Reporting Manager
Context Capital Management, LLC
Symbol
BIORQ
Shares outstanding
4,405,000 shares
Disclosed Ownership
22,025 shares
Ownership
0.5%
Form type
SCHEDULE 13G/A
Filing time
10 Jul 2025, 09:51:26 UTC
Date of event
30 Jun 2025

Key filing fact

Context Capital Management, LLC disclosed 0.5% ownership in BIORA THERAPEUTICS, INC. Common Stock (BIORQ) on 30 Jun 2025.

Key facts

  • Context Capital Management, LLC filed SCHEDULE 13G/A for BIORA THERAPEUTICS, INC. Common Stock (BIORQ).
  • Disclosed ownership: 0.5%.
  • Date of event: 30 Jun 2025.

Change

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 10 Jul 2025, 09:51.

Research use

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting persons

Reporting managers (5)

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Context Capital Management, LLC 0.5% 22,025 0 22,025 Michael S. Rosen CEO
Michael S. Rosen 0.5% 22,025 0 22,025 Michael S. Rosen CEO
William D. Fertig 0.5% 22,025 0 22,025 William D. Fertig Chairman
Charles E. Carnegie 0.5% 22,025 0 22,025 Charles E. Carnegie CIO
Context Partners Master Fund, L.P. 0.5% 22,025 0 22,025 Michael S. Rosen CEO
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .